DAVITA INC.
DVAAPI behind this page
DVA FY 2025 request
Playground key active
/api/financials?ticker=DVA&year=2025&quarter=4&full_year_mode=true
Pick an endpoint and run the request.Income Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts | 13,007,186 | 12,260,375 | +6.1% |
| Other Income | 635,883 | 555,175 | +14.5% |
Show Business Segments breakouts |
|||
| All Other Segments · Commercial Payors | 15,399 | 21,396 | -28.0% |
| All Other Segments · Medicaid and Managed Medicaid | 2 | 740 | -99.7% |
| All Other Segments · Medicare and Medicare Advantage | 507,613 | 463,731 | +9.5% |
| All Other Segments · Other | 99,462 | 58,862 | +69.0% |
| Other Operating Segments with Intersegment · Operating Segments | 611,273 | 530,819 | +15.2% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 24,610 | 24,356 | +1.0% |
| U S Dialysis · Other | 24,610 | 24,356 | +1.0% |
Show Health Care Organization Revenue Sources breakouts |
|||
| Commercial Payors | 15,399 | 21,396 | -28.0% |
| Medicaid and Managed Medicaid | 2 | 740 | -99.7% |
| Medicare and Medicare Advantage | 507,613 | 463,731 | +9.5% |
| Other | 124,072 | 83,218 | +49.1% |
| Revenue | 13,643,069 | 12,815,550 | +6.5% |
Show Business Segments breakouts |
|||
| All Other Segments | 1,911,083 | 1,496,580 | +27.7% |
| All Other Segments · Intersegment Elimination | -11,203 | -13,910 | +19.5% |
| Other Operating Segments with Intersegment · Operating Segments | 1,922,286 | 1,510,490 | +27.3% |
| U S Dialysis | 11,731,986 | 11,318,970 | +3.6% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 11,792,944 | 11,390,717 | +3.5% |
| U S Dialysis · Intersegment Elimination | -60,958 | -71,747 | +15.0% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -72,161 | -85,657 | +15.8% |
| Operating Segments | 13,715,230 | 12,901,207 | +6.3% |
| Patient Care Costs | 9,243,476 | 8,598,521 | +7.5% |
Show Business Segments breakouts |
|||
| U S Dialysis · Operating Segments | 7,854,234 | 7,497,576 | +4.8% |
| General & Administrative | 1,673,630 | 1,538,341 | +8.8% |
Show Business Segments breakouts |
|||
| U S Dialysis · Operating Segments | 1,253,298 | 1,173,990 | +6.8% |
| Depreciation And Amortization | 715,348 | 723,860 | -1.2% |
Show Business Segments breakouts |
|||
| All Other Segments | 81,952 | 62,679 | +30.7% |
| U S Dialysis · Operating Segments | 633,396 | 661,181 | -4.2% |
| Income Loss From Equity Method Investments | -33,000 | -26,189 | -26.0% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | -783 | 1,701 | -146.0% |
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts |
|||
| Equity Method Investments In Nonconsolidated Dialysis Partnerships | -33,000 | -26,189 | -26.0% |
| Total Costs & Expenses | 11,599,454 | 10,725,067 | +8.2% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 1,829,907 | 1,427,833 | +28.2% |
| U S Dialysis · Operating Segments | 9,708,711 | 9,269,710 | +4.7% |
| Operating Income | 2,043,615 | 2,090,483 | -2.2% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 92,379 | 82,657 | +11.8% |
| U S Dialysis · Operating Segments | 2,084,233 | 2,121,007 | -1.7% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 2,176,612 | 2,203,664 | -1.2% |
| Interest And Debt Expense | -579,926 | -470,469 | -23.3% |
| Debt Prepayment Extinguishment And Modification Costs | -14,178 | -19,813 | +28.4% |
| Other Non-Operating Income (Expense) | -102,688 | -69,808 | -47.1% |
| Income Before Taxes | 1,346,823 | 1,530,393 | -12.0% |
| Income Tax Expense (Benefit) | 293,107 | 279,656 | +4.8% |
Show Statement Operating Activities Segment breakouts |
|||
| Segment Continuing Operations | 293,107 | 279,656 | +4.8% |
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | 1,053,716 | 1,250,737 | -15.8% |
| Income Loss From Discontinued Operations Net Of Tax | 25,000 | — | — |
| Net Income | 1,078,716 | 1,250,737 | -13.8% |
| Net Income Loss Attributable To Noncontrolling Interest | -331,913 | -314,395 | -5.6% |
| Net Income | 746,803 | 936,342 | -20.2% |
| Income Loss From Continuing Operations Per Basic Share | 9.72 | 11.02 | -11.8% |
| EPS (Basic) | 10.06 | 11.02 | -8.7% |
| Income Loss From Continuing Operations Per Diluted Share | 9.51 | 10.73 | -11.4% |
| EPS (Diluted) | 9.84 | 10.73 | -8.3% |
| Wtd Avg Shares (Basic) | 74,227 | 84,991 | -12.7% |
| Wtd Avg Shares (Diluted) | 75,885 | 87,274 | -13.0% |
| Income Loss From Continuing Operations | 721,803 | 936,342 | -22.9% |
| Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity | 25,000 | — | — |
| Comprehensive Income | 934,816 | 677,630 | +38.0% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | -21,321 | 7,250 | -394.1% |
Show Derivative Instruments Gain Loss By Hedging Relationship breakouts |
|||
| Cash Flow Hedging | -21,321 | 7,250 | -394.1% |
| Revenue From Contract With Customer Including Assessed Tax (FY) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Commercial Payors | 385,423 | 248,026 | +55.4% |
| All Other Segments · Other Government Payors | 914,387 | 717,735 | +27.4% |
| Other Operating Segments with Intersegment · Operating Segments | 1,299,810 | 965,761 | +34.6% |
| Other Operating Segments with Intersegment · Operating Segments | 11,203 | 13,910 | -19.5% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 11,768,334 | 11,366,361 | +3.5% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 11,707,376 | 11,294,614 | +3.7% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 60,958 | 71,747 | -15.0% |
| U S Dialysis · Commercial Payors | 3,806,596 | 3,783,827 | +0.6% |
| U S Dialysis · Medicaid and Managed Medicaid | 871,695 | 863,947 | +0.9% |
| U S Dialysis · Medicare and Medicare Advantage | 6,740,392 | 6,374,882 | +5.7% |
| U S Dialysis · Other Government Payors | 349,651 | 343,705 | +1.7% |
Show Health Care Organization Revenue Sources breakouts |
|||
| Commercial Payors | 4,192,019 | 4,031,853 | +4.0% |
| Medicaid and Managed Medicaid | 871,695 | 863,947 | +0.9% |
| Medicare and Medicare Advantage | 6,740,392 | 6,374,882 | +5.7% |
| Other Government Payors | 1,264,038 | 1,061,440 | +19.1% |
Balance Sheet
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 676,438 | 794,933 | -14.9% |
| Marketable Securities (Current) | 24,303 | 51,064 | -52.4% |
| Accounts Receivable | 2,414,690 | 2,146,975 | +12.5% |
Show Health Care Organization Revenue Sources breakouts |
|||
| Medicare bad debt claims | 881,191 | 768,536 | +14.7% |
| Inventory | 160,627 | 134,559 | +19.4% |
| Other Receivables Net Current | 494,414 | 383,166 | +29.0% |
Show Accounts Notes Loans And Financing Receivable By Receivable Type breakouts |
|||
| Supplier rebates and non-trade receivables | 222,615 | 132,095 | +68.5% |
| Prepaid Expenses & Other Current Assets | 156,285 | 122,948 | +27.1% |
| Total Current Assets | 4,058,003 | 3,746,072 | +8.3% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,812,966 | 2,940,916 | -4.4% |
Show Business Segments breakouts |
|||
| All Other Segments · Non Us | 399,423 | 317,488 | +25.8% |
| Operating Lease Right-of-Use Assets | 2,397,179 | 2,393,558 | +0.2% |
| Marketable Securities (Non-Current) | 40,966 | 33,660 | +21.7% |
| Other Non-Current Assets | 246,520 | 261,731 | -5.8% |
| Goodwill | 7,545,095 | 7,375,216 | +2.3% |
Show Business Segments breakouts |
|||
| All Other Segments | 1,017,479 | 857,996 | +18.6% |
| U S Dialysis | 6,527,616 | 6,517,220 | +0.2% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | 71,684 | 349,069 | -79.5% |
| Total Assets | 17,480,103 | 17,285,268 | +1.1% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 640,481 | — | — |
| Intangible Assets (Q) | — | — | — |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Service Agreements | 45,025 | — | — |
| Other Assets | |||
| Restricted Cash And Cash Equivalents | 81,309 | 84,892 | -4.2% |
| Income Taxes Receivable | 49,937 | 27,535 | +81.4% |
| Intangible Assets Net Excluding Goodwill | 222,125 | 197,431 | +12.5% |
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 157,249 | 336,684 | -53.3% |
Show Investment Type breakouts |
|||
| Equity Securities | 23,763 | 21,732 | +9.3% |
Show Partner Type Of Partners Capital Account breakouts |
|||
| Other Ownership Interest | 133,486 | 99,246 | +34.5% |
| Current Liabilities | |||
| Accounts Payable | 696,148 | 547,200 | +27.2% |
| Other Liabilities Current | 893,024 | 934,145 | -4.4% |
| Employee Related Liabilities Current | 793,478 | 800,484 | -0.9% |
| Operating Lease Liability Current | 425,484 | 410,411 | +3.7% |
| Long Term Debt And Capital Lease Obligations Current | 109,201 | 270,867 | -59.7% |
| Accrued Income Taxes Current | 24,359 | 10,303 | +136.4% |
| Total Current Liabilities | 3,141,634 | 2,973,410 | +5.7% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities | 2,175,658 | 2,209,655 | -1.5% |
| Other Non-Current Liabilities | 83,516 | 169,588 | -50.8% |
| Deferred Tax Liabilities | 756,869 | 665,361 | +13.8% |
| Total Liabilities | 16,321,665 | 15,193,917 | +7.4% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 215,650 | — | — |
| Other Liabilities | |||
| Due To Related Party | 199,940 | — | — |
| Long Term Debt And Capital Lease Obligations | 10,163,988 | 9,175,903 | +10.8% |
| Stockholders' Equity | |||
| Common Stock | 69 | 90 | -23.3% |
| Retained Earnings | -328,428 | 1,534,630 | -121.4% |
| Treasury Stock Value | -199,940 | -1,389,072 | +85.6% |
| Accumulated Other Comprehensive Income | -122,783 | -310,796 | +60.5% |
| Total Stockholders' Equity | -651,082 | 121,122 | -637.5% |
| Minority Interest | 277,354 | 274,746 | +0.9% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -373,728 | 395,868 | -194.4% |
Show Equity Components breakouts |
|||
| Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest | -100,385 | -302,285 | +66.8% |
| Accumulated Gain Loss Cash Flow Hedge Including Noncontrolling Interest | -22,398 | -8,557 | -161.8% |
| Accumulated Other Comprehensive Income | -122,783 | -310,796 | +60.5% |
| Aoci Including Portion Attributable To Noncontrolling Interest | -122,783 | -310,796 | +60.5% |
| Common Stock | 69 | 90 | -23.3% |
| Noncontrolling Interest | 277,354 | 274,746 | +0.9% |
| Parent | -651,082 | 121,122 | -637.5% |
| Retained Earnings | -328,428 | 1,534,630 | -121.4% |
| Treasury Stock Common | -199,940 | -1,389,072 | +85.6% |
| Total Liabilities & Equity | 17,480,103 | 17,285,268 | +1.1% |
| Common Stock Par Or Stated Value Per Share | 0 | 0 | 0.0% |
| Common Stock Shares Authorized | 450,000 | 450,000 | 0.0% |
| Common Stock Shares Issued | 68,549 | 90,369 | -24.1% |
| Redeemable Noncontrolling Interest Equity Carrying Amount | 1,532,166 | 1,695,483 | -9.6% |
| Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0.0% |
| Preferred Stock Shares Authorized | 5,000 | 5,000 | 0.0% |
Cash Flow Statement
| Metric | FY 2025 | FY 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation Amortization And Accretion Net | 715,348 | 723,860 | -1.2% |
| Loss On Extinguishment Of Debt | 12,386 | 12,527 | -1.1% |
| Stock-Based Compensation | 139,953 | 102,788 | +36.2% |
| Deferred Income Taxes | 86,574 | -57,840 | +249.7% |
| Adjustment Income Loss From Equity Method Investments | 134,313 | 115,839 | +15.9% |
| Other Non-Cash Items | -17,549 | 13,414 | -230.8% |
| Change in Accounts Receivable | -210,632 | -29,766 | -607.6% |
| Change in Inventory | -19,950 | 17,942 | -211.2% |
| Increase Decrease In Other Current Receivables And Other Current Assets | -124,297 | 36,801 | -437.8% |
| Increase Decrease In Other Noncurrent Assets | -40,253 | -67,031 | +39.9% |
| Change in Accounts Payable | 128,303 | 1,699 | +7451.7% |
| Increase Decrease In Employee Related Liabilities | -24,042 | 14,687 | -263.7% |
| Increase Decrease In Other Current Liabilities | -29,963 | 46,733 | -164.1% |
| Increase Decrease In Accrued Income Taxes Payable | 50,245 | -44,214 | +213.6% |
| Change in Other Liabilities | 7,348 | -6,672 | +210.1% |
| Net Cash from Operations | 1,886,500 | 2,022,038 | -6.7% |
| Depreciation & Amortization | 708,252 | 716,396 | -1.1% |
| Investing Activities | |||
| Capital Expenditures | -575,864 | -555,443 | -3.7% |
| Payments To Acquire Businesses Net Of Cash Acquired | -117,468 | -246,068 | +52.3% |
| Proceeds From Sales Of Business Affiliate And Productive Assets | 34,173 | 25,862 | +32.1% |
| Payments To Acquire Held To Maturity Securities | -16,405 | -15,319 | -7.1% |
| Payments To Acquire Other Debt And Equity Investments | -6,031 | -9,140 | +34.0% |
| Proceeds From Sale And Maturity Of Held To Maturity Securities | 45,413 | 22,638 | +100.6% |
| Proceeds From Sale And Maturity Of Other Investments | 6,723 | 4,566 | +47.2% |
| Payments To Acquire Equity Method Investments | -27,030 | -5,205 | -419.3% |
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | 1,540 | 6,680 | -76.9% |
| Net Cash from Investing | -654,949 | -771,429 | +15.1% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 5,612,280 | 6,624,310 | -15.3% |
| Repayments Of Debt And Capital Lease Obligations | -4,788,845 | -5,515,213 | +13.2% |
| Payments Of Financing Costs | -53,819 | -50,874 | -5.8% |
| Purchase Of Treasury Stock From Related Party | -484,633 | — | — |
| Share Repurchases | -1,308,366 | -1,385,932 | +5.6% |
| Payments Of Distributions To Affiliates | -324,270 | -337,042 | +3.8% |
| Net Proceeds From Issuance Of Stock To Employees | 23,290 | 20,453 | +13.9% |
| Tax Withholding for Share Compensation | -35,291 | -134,040 | +73.7% |
| Proceeds From Contributions From Affiliates | 7,078 | 14,499 | -51.2% |
| Proceeds From Minority Shareholders | 3,794 | 860 | +341.2% |
| Payments To Minority Shareholders | -25,998 | -53,958 | +51.8% |
| Net Cash from Financing | -1,374,780 | -816,937 | -68.3% |
| Amortization of Financing Costs | 40,002 | 35,266 | +13.4% |
| Supplemental | |||
| Income Taxes Paid | 176,688 | 387,940 | -54.5% |
| Interest Paid | 515,497 | 423,360 | +21.8% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 21,151 | -18,481 | +214.4% |
| Net Change in Cash | -122,078 | 415,191 | -129.4% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 757,747 | 879,825 | -13.9% |
Values in thousands USD. Source: SEC EDGAR 10-K filing.